Integration potential of mouse and human bone marrow-derived mesenchymal stem cells

Differentiation

Volumn 83, Issue 3, 2012, Pages 128-137

  Kuzma Kuzniarska, Maria ^a   Rak Raszewska, Aleksandra ^a   Kenny, Simon ^a   Edgar, David ^a   Wilm, Bettina ^a   Fuente Mora, Cristina ^a   Davies, Jamie A ^a   Murray, Patricia ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Development; Embryonic kidney; MSCs; Nephrogenesis; Stem cells

Indexed keywords

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL POPULATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; EMBRYO CULTURE; EMBRYONIC STEM CELL; EX VIVO STUDY; GENE EXPRESSION; GENE FUNCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KIDNEY DEVELOPMENT; KIDNEY PARENCHYMA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; KIDNEY; MESENCHYMAL STEM CELLS; MICE; PARACRINE COMMUNICATION;

EID: 84857205682     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.11.004     Document Type: Article

References (63)

1. Armstrong J.F., Pritchard-Jones K., Bickmore W.A., Hastie N.D., Bard J.B. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev. 1993, 40:85-97.
2. Baer P.C., Bereiter-Hahn J., Missler C., Brzoska M., Schubert R., Gauer S., Geiger H. Conditioned medium from renal tubular epithelial cells initiates differentiation of human mesenchymal stem cells. Cell Prolif. 2009, 42:29-37.
3. Bi B., Schmitt R., Israilova M., Nishio H., Cantley L.G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 2007, 18:2486-2496.
4. Bruno S., Grange C., Deregibus M.C., Calogero R.A., Saviozzi S., Collino F., Morando L., Busca A., Falda M., Bussolati B., Tetta C., Camussi G. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 2009, 20:1053-1067.
5. Buck A., Kispert A., Kohlhase J. Embryonic expression of the murine homologue of SALL1, the gene mutated in Townes-Brocks syndrome. Mech. Dev. 2001, 104:143-146.
6. Butler D.L., Gooch C., Kinneberg K.R., Boivin G.P., Galloway M.T., Nirmalanandhan V.S., Shearn J.T., Dyment N.A., Juncosa-Melvin N. The use of mesenchymal stem cells in collagen-based scaffolds for tissue-engineered repair of tendons. Nat. Protoc. 2010, 5:849-863.
7. Davies J. Control of calbindin-D28K expression in developing mouse kidney. Dev. Dyn. 1994, 199:45-51.
8. Diduch D.R., Coe M.R., Joyner C., Owen M.E., Balian G. Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J. Bone Joint Surg. Am. 1993, 75:92-105.
9. Dudley A.T., Godin R.E., Robertson E.J. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev. 1999, 13:1601-1613.
10. Ekblom P. Formation of basement membranes in the embryonic kidney: an immunohistological study. J. Cell Biol. 1981, 91:1-10.
11. Fuente Mora C., Ranghini E., Bruno B., Bussolati B., Camussi G., Wilm B., Edgar D., Kenny S., Murray P. Differentiation of podocyte and proximal tubule-like cells from a mouse kidney-derived stem cell line. Stem Cells Dev. 2011, epub ahead of print. 10.1089/scd.2010.0470.
12. Fukui A., Yokoo T., Matsumoto K., Kawamura T., Hosoya T., Okabe M. Integration of human mesenchymal stem cells into the Wolffian duct in chicken embryos. Biochem. Biophys. Res. Commun. 2009, 385:330-335.
13. Guillot P.V., Cook H.T., Pusey C.D., Fisk N.M., Harten S., Moss J., Shore I., Bou-Gharios G. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J. Pathol. 2008, 214:627-636.
14. Guo Z., Li H., Li X., Yu X., Wang H., Tang P., Mao N. In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 2006, 24:992-1000.
15. Hatini V., Huh S.O., Herzlinger D., Soares V.C., Lai E. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev. 1996, 10:1467-1478.
16. Herrera M.B., Bussolati B., Bruno S., Fonsato V., Romanazzi G.M., Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int. J. Mol. Med. 2004, 14:1035-1041.
17. Horn A.P., Frozza R.L., Grudzinski P.B., Gerhardt D., Hoppe J.B., Bruno A.N., Chagastelles P., Nardi N.B., Lenz G., Salbego C. Conditioned medium from mesenchymal stem cells induces cell death in organotypic cultures of rat hippocampus and aggravates lesion in a model of oxygen and glucose deprivation. Neurosci. Res. 2009, 63:35-41.
18. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. U S A 2002, 99:8932-8937.
19. Juffroy O., Noel D., Delanoye A., Viltart O., Wolowczuk I., Verwaerde C. Subcutaneous graft of D1 mouse mesenchymal stem cells leads to the formation of a bone-like structure. Differentiation 2009, 78:223-231.
20. Kim D., Dressler G.R. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J. Am. Soc. Nephrol. 2005, 16:3527-3534.
21. Kim S.S., Park H.J., Han J., Gwak S.J., Park M.H., Song K.W., Rhee Y.H., Min Chung H., Kim B.S. Improvement of kidney failure with fetal kidney precursor cell transplantation. Transplantation 2007, 83:1249-1258.
22. Kobayashi A., Kwan K.M., Carroll T.J., McMahon A.P., Mendelsohn C.L., Behringer R.R. Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development. Development 2005, 132:2809-2823.
23. Kondo T., Johnson S.A., Yoder M.C., Romand R., Hashino E. Sonic hedgehog and retinoic acid synergistically promote sensory fate specification from bone marrow-derived pluripotent stem cells. Proc. Natl. Acad. Sci. U S A 2005, 102:4789-4794.
24. Kunter U., Rong S., Boor P., Eitner F., Muller-Newen G., Djuric Z., van Roeyen C.R., Konieczny A., Ostendorf T., Villa L., Milovanceva-Popovska M., Kerjaschki D., Floege J. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 2007, 18:1754-1764.
25. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., Ringden O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
26. Liu C.H., Hwang S.M. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005, 32:270-279.
27. Mendelsohn C., Batourina E., Fung S., Gilbert T., Dodd J. Stromal cells mediate retinoid-dependent functions essential for renal development. Development 1999, 126:1139-1148.
28. Miyazaki Y., Oshima K., Fogo A., Ichikawa I. Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int. 2003, 63:835-844.
29. Morigi M., Imberti B., Zoja C., Corna D., Tomasoni S., Abbate M., Rottoli D., Angioletti S., Benigni A., Perico N., Alison M., Remuzzi G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004, 15:1794-1804.
30. Morigi M., Rota C., Montemurro T., Montelatici E., Lo Cicero V., Imberti B., Abbate M., Zoja C., Cassis P., Longaretti L., Rebulla P., Introna M., Capelli C., Benigni A., Remuzzi G., Lazzari L. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010, 28:513-522.
31. Mugford J.W., Sipila P., McMahon J.A., McMahon A.P. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev. Biol. 2008, 324:88-98.
32. Muller-Borer B.J., Collins M.C., Gunst P.R., Cascio W.E., Kypson A.P. Quantum dot labeling of mesenchymal stem cells. J. Nanobiotechnology 2007, 5:9.
33. Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A., Zabel B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993, 119:1329-1341.
34. Ninichuk V., Gross O., Segerer S., Hoffmann R., Radomska E., Buchstaller A., Huss R., Akis N., Schlondorff D., Anders H.J. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 2006, 70:121-129.
35. Pan R.L., Chen Y., Xiang L.X., Shao J.Z., Dong X.J., Zhang G.R. Fetal liver-conditioned medium induces hepatic specification from mouse bone marrow mesenchymal stromal cells: a novel strategy for hepatic transdifferentiation. Cytotherapy 2008, 10:668-675.
36. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004, 103:1662-1668.
37. Perin L., Giuliani S., Jin D., Sedrakyan S., Carraro G., Habibian R., Warburton D., Atala A., De Filippo R.E. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007, 40:936-948.
38. Pi M., Zhang W., Zhou G., Liu W., Cao Y. Degradation or excretion of quantum dots in mouse embryonic stem cells. BMC Biotechnol. 2010, 10:36.
39. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
40. Ranjbarvaziri S., Kiani S., Akhlaghi A., Vosough A., Baharvand H., Aghdami N. Quantum dot labeling using positive charged peptides in human hematopoetic and mesenchymal stem cells. Biomaterials 2011, 32:5195-5205.
41. Rogers S.A., Lowell J.A., Hammerman N.A., Hammerman M.R. Transplantation of developing metanephroi into adult rats. Kidney Int. 1998, 54:27-37.
42. Rosen A.B., Kelly D.J., Schuldt A.J., Lu J., Potapova I.A., Doronin S.V., Robichaud K.J., Robinson R.B., Rosen M.R., Brink P.R., Gaudette G.R., Cohen I.S. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25:2128-2138.
43. Rosines E., Sampogna R.V., Johkura K., Vaughn D.A., Choi Y., Sakurai H., Shah M.M., Nigam S.K. Staged in vitro reconstitution and implantation of engineered rat kidney tissue. Proc. Natl. Acad. Sci. U S A 2007, 104:20938-20943.
44. Rothenpieler U.W., Dressler G.R. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development 1993, 119:711-720.
45. Sainio K., Suvanto P., Davies J., Wartiovaara J., Wartiovaara K., Saarma M., Arumae U., Meng X., Lindahl M., Pachnis V., Sariola H. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 1997, 124:4077-4087.
46. Schinkothe T., Bloch W., Schmidt A. In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev. 2008, 17:199-206.
47. Schittini A.V., Celedon P.F., Stimamiglio M.A., Krieger M., Hansen P., da Costa F.D., Goldenberg S., Dallagiovanna B., Correa A. Human cardiac explant-conditioned medium: soluble factors and cardiomyogenic effect on mesenchymal stem cells. Exp. Biol. Med. (Maywood) 2010, 235:1015-1024.
48. Sebinger D.D., Unbekandt M., Ganeva V.V., Ofenbauer A., Werner C., Davies J.A. A novel, low-volume method for organ culture of embryonic kidneys that allows development of cortico-medullary anatomical organization. PLoS One 2010, 5:e10550.
49. Self M., Lagutin O.V., Bowling B., Hendrix J., Cai Y., Dressler G.R., Oliver G. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J. 2006, 25:5214-5228.
50. Shen F.H., Visger J.M., Balian G., Hurwitz S.R., Diduch D.R. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J. Orthop. Trauma 2002, 16:651-659.
51. Siegel N., Rosner M., Unbekandt M., Fuchs C., Slabina N., Dolznig H., Davies J.A., Lubec G., Hengstschlager M. Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum. Mol. Genet. 2010, 19:3320-3331.
52. Sims-Lucas S., Young R.J., Martinez G., Taylor D., Grimmond S.M., Teasdale R., Little M.H., Bertram J.F., Caruana G. Redirection of renal mesenchyme to stromal and chondrocytic fates in the presence of TGF-beta2. Differentiation 2010, 79:272-284.
53. Squitti R., De Stefano M.E., Edgar D., Toschi G. Effects of axotomy on the expression and ultrastructural localization of N-cadherin and neural cell adhesion molecule in the quail ciliary ganglion: an in vivo model of neuroplasticity. Neuroscience 1999, 91:707-722.
54. Steenhard B.M., Isom K.S., Cazcarro P., Dunmore J.H., Godwin A.R., John P.L., Abrahamson D.R. Integration of embryonic stem cells in metanephric kidney organ culture. J. Am. Soc. Nephrol. 2005, 16:1623-1631.
55. Thirabanjasak D., Tantiwongse K., Thorner P.S. Angiomyeloproliferative lesions following autologous stem cell therapy. J. Am. Soc. Nephrol. 2010, 21:1218-1222.
56. Togel F., Hu Z., Weiss K., Isaac J., Lange C., Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 2005, 289:F31-F42.
57. Togel F., Weiss K., Yang Y., Hu Z., Zhang P., Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol. 2007, 292:F1626-F1635.
58. Togel F., Cohen A., Zhang P., Yang Y., Hu Z., Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009, 18:475-485.
59. Unbekandt M., Davies J.A. Dissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues. Kidney Int. 2010, 77:407-416.
60. Vigneau C., Polgar K., Striker G., Elliott J., Hyink D., Weber O., Fehling H.J., Keller G., Burrow C., Wilson P. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J. Am. Soc. Nephrol. 2007, 18:1709-1720.
61. Weller A., Sorokin L., Illgen E.M., Ekblom P. Development and growth of mouse embryonic kidney in organ culture and modulation of development by soluble growth factor. Dev. Biol. 1991, 144:248-261.
62. Yokoo T., Ohashi T., Shen J.S., Sakurai K., Miyazaki Y., Utsunomiya Y., Takahashi M., Terada Y., Eto Y., Kawamura T., Osumi N., Hosoya T. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc. Natl. Acad. Sci. U S A 2005, 102:3296-3300.
63. Yokoo T., Fukui A., Ohashi T., Miyazaki Y., Utsunomiya Y., Kawamura T., Hosoya T., Okabe M., Kobayashi E. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J. Am. Soc. Nephrol. 2006, 17:1026-1034.